UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nickel chloride induces anticancer biological responses in hepatocellular carcinoma cell lines

Toxicology and industrial health, 2023-02, Vol.39 (2), p.94-103

2023

Volltextzugriff (PDF)

Algorithms for scheduling of chemotherapy plans

Computers in biology and medicine, 2013-12, Vol.43 (12), p.2103-2109

2013

Volltextzugriff (PDF)

Boric acid exert anti-cancer effect in poorly differentiated hepatocellular carcinoma cells via inhibition of AKT signaling pathway

Journal of trace elements in medicine and biology, 2022-09, Vol.73, p.127043-127043, Article 127043

2022

Volltextzugriff (PDF)

Antifungal imidazole: Potential new antineoplastic agent-cytotoxic effects on non-small cell lung cancer cell lines (A549)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21037-e21037

2021

Volltextzugriff (PDF)

Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways

Molecular biology reports, 2022-06, Vol.49 (6), p.4377-4388

2022

Volltextzugriff (PDF)

Fat replacement of the malignant pancreatic tissue after neoadjuvant therapy

International journal of clinical oncology, 2010-02, Vol.15 (1), p.88-92

2010

Volltextzugriff (PDF)

Synthesis and characterization of folic acid-chitosan nanoparticles loaded with thymoquinone to target ovarian cancer cells

Journal of radioanalytical and nuclear chemistry, 2020-04, Vol.324 (1), p.71-85

2020

Volltextzugriff (PDF)

Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines

Clinical cancer research, 2000-12, Vol.6 (12), p.4957-4964

2000

Volltextzugriff (PDF)

Sequential usage of imidazole followed by tamoxifen to enhance the anticancer effect of tamoxifen in estrogen receptor-positive breast cancer cell lines

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15057-e15057

2021

Volltextzugriff (PDF)

Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations

Lung cancer (Amsterdam, Netherlands), 2021-08, Vol.158, p.60-73

2021

Volltextzugriff (PDF)

Caffeic acid phenethyl ester (CAPE) Chitosan capped ZnO nanoparticles: Preparation, characterization, and its potential for the treatment of prostate cancer

Journal of molecular structure, 2024-09, Vol.1312, p.138562, Article 138562

2024

Volltextzugriff (PDF)

Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations

International journal of clinical oncology, 2015-04, Vol.20 (2), p.395-404

2015

Volltextzugriff (PDF)

Predictive role of neutropenia under crizotinib treatment in ALK-rearranged nonsmall cell lung cancer patients: A single-institution retrospective analysis

Indian journal of cancer, 2022-04, Vol.59 (2), p.251-256

2022

Volltextzugriff (PDF)

EFFECTS OF NICKEL CHLORIDE ON CELL MORPHOLOGY AND MIGRATION IN NON-SMALL CELL LUNG CANCER CELL LINES

Turkish medical student journal, 2023-10, Vol.10 (3), p.112-115

2023

Volltextzugriff (PDF)

PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?

European journal of obstetrics & gynecology and reproductive biology, 2024-05, Vol.296, p.321-326

2024

Volltextzugriff (PDF)

Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways

Eurasian journal of medical investigation, 2024, p.13-20

Almuradova, Elvina

2024

Volltextzugriff (PDF)

Intrinsic and Acquired Resistance to Methotrexate in Acute Leukemia

The New England journal of medicine, 1996-10, Vol.335 (14), p.1041-1048

1996

Volltextzugriff (PDF)

Smoking Status in Relation to Clinicopathological Characteristics, Oncological Outcome, and Presence of Second Primary Lung Cancer in Patients with Bladder Cancer: A Population-based Registry Study

Üroonkoloji bülteni, 2023-12, Vol.22 (4), p.144-149

2023

Volltextzugriff (PDF)

Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience

Turkish Thoracic Journal, 2022-07, Vol.23 (4), p.290-295

2022

Volltextzugriff (PDF)

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Lung cancer (Amsterdam, Netherlands), 2017-07, Vol.109, p.101-108

2017

Volltextzugriff (PDF)

Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group

Current problems in cancer, 2023-12, Vol.47 (6), p.101017-101017, Article 101017

2023

Volltextzugriff (PDF)

Alectinib in Resected ALK -Positive Non-Small-Cell Lung Cancer

The New England journal of medicine, 2024-04, Vol.390 (14), p.1265-1276

2024

Volltextzugriff (PDF)

Nutritional Aspect of Cancer Care in Medical Oncology Patients

Clinical therapeutics, 2019-11, Vol.41 (11), p.2382-2396

2019

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nickel chloride induces anticancer biological responses in hepatocellular carcinoma cell lines

Algorithms for scheduling of chemotherapy plans

Boric acid exert anti-cancer effect in poorly differentiated hepatocellular carcinoma cells via inhibition of AKT signaling pathway

Antifungal imidazole: Potential new antineoplastic agent-cytotoxic effects on non-small cell lung cancer cell lines (A549)

Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Fat replacement of the malignant pancreatic tissue after neoadjuvant therapy

Synthesis and characterization of folic acid-chitosan nanoparticles loaded with thymoquinone to target ovarian cancer cells

Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines

Sequential usage of imidazole followed by tamoxifen to enhance the anticancer effect of tamoxifen in estrogen receptor-positive breast cancer cell lines

Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations

Caffeic acid phenethyl ester (CAPE) Chitosan capped ZnO nanoparticles: Preparation, characterization, and its potential for the treatment of prostate cancer

Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations

Predictive role of neutropenia under crizotinib treatment in ALK-rearranged nonsmall cell lung cancer patients: A single-institution retrospective analysis

EFFECTS OF NICKEL CHLORIDE ON CELL MORPHOLOGY AND MIGRATION IN NON-SMALL CELL LUNG CANCER CELL LINES

PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?

Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways

Intrinsic and Acquired Resistance to Methotrexate in Acute Leukemia

Smoking Status in Relation to Clinicopathological Characteristics, Oncological Outcome, and Presence of Second Primary Lung Cancer in Patients with Bladder Cancer: A Population-based Registry Study

Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group

Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial

Alectinib in Resected ALK -Positive Non-Small-Cell Lung Cancer

Nutritional Aspect of Cancer Care in Medical Oncology Patients

Suchergebnisse filtern